Aberrant up-regulation of hnRNPC has been observed in a variety of cancers or cancer cell lines including breast cancers, glioblastomas, hepatocellular carcinomas, ovarian cancers, and lung cancers [159–163, 173]. Here, HNRNPC is linked to cancer.